Skip to main content
Central European Journal of Urology logoLink to Central European Journal of Urology
. 2024 Jan 31;77(1):140–151. doi: 10.5173/ceju.2023.233

Regional versus general anaesthesia in percutaneous nephrolithotomy: a systematic review and meta-analysis

Mohammed Shahait 1, Tuan Thanh Nguyen 2, Nguyen Xuong Duong 3, Philip Mucksavage 4, Bhaskar K Somani 5,
PMCID: PMC11032030  PMID: 38645811

Abstract

Introduction

Several studies have compared the safety and effectiveness of general and regional anaesthesia in percutaneous nephrolithotomy (PCNL). This study aimed to compare the perioperative and postoperative outcomes of general anaesthesia and regional anaesthesia for patients undergoing PCNL.

Material and methods

For relevant articles, three electronic databases, including PubMed, Scopus, and Web of Science, were searched from their inception until March 2023. A meta-analysis has been reported in line with PRISMA 2020 and AMSTAR Guidelines. The risk ratio (RR) and mean difference (MD) were applied for the comparison of dichotomous and continuous variables with 95% confidence intervals (CI).

Results

The final cohort analysis, comprised 3871 cases of PCNL, (2154 regional anaesthesia and 1717 general anaesthesia). Compared to general anaesthesia, the regional anaesthesia group had a significantly shorter length of stay (MD = -0.34 days, 95% CI -0.56 to -0.12, p = 0.002), lower postoperative nausea and vomiting rates (RR = 0.16, 95% CI 0.03 to 0.80, p = 0.026), lower complications grade III–V rates (RR = 0.68, 95% CI 0.53 to 0.88, p = 0.004), and lower postoperative visual analogue pain score (VAS) at 1 hour (MD = -3.5, 95% CI -4.1 to -2.9, p <0.001). There were no significant differences in other outcomes between the two groups.

Conclusions

Our results show that PCNL under regional anaesthesia is safe and feasible, with comparable results to those done under general anaesthesia. While patient selection is important, counselling and decision-making for these procedures must go hand in hand to achieve the best clinical outcome.

Keywords: kidney calculi, percutaneous nephrolithotomy, PCNL, regional anaesthesia

INTRODUCTION

Percutaneous nephrolithotomy (PCNL) is a minimally invasive procedure commonly used in Endourology and has become the standard for managing large and complex renal calculi [1]. From the first report by Fernstrom and Johansson in 1976, PCNL techniques have been modified to ameliorate safety, efficacy, and decrease morbidity [2].

In PCNL procedures, the choice of anaesthesia impacts the outcomes, especially in minimising respiratory complications and length of hospital stay. Both general anaesthesia and regional anaesthesia have their advantages. While general anaesthesia dominates in controlling patients’ breathing and improving their comfort, regional anaesthesia has advantages with its lower rate of postoperative drug reactions and shorter procedural duration and hospital stay [1]. Many studies have compared the safety and effectiveness of general and regional anaesthesia in the PCNL. However, the conclusions are inconsistent, and there is a lack of agreement on the optimal anaesthesia setting for PCNL. This study aimed to compare the perioperative and postoperative outcomes of general anaesthesia and regional anaesthesia for patients undergoing PCNL.

MATERIAL AND METHODS

Literature search

This study was conducted following the accepted methodology recommendations of PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) and AMSTAR (Assessing the Methodological Quality of Systematic Reviews) [3,4]. Three electronic databases, Scopus, Web of Science (ISI), and PubMed were searched to identify relevant studies regarding perioperative and post-operative outcomes of patients undergoing PCNL under regional anaesthesia or general anaesthesia from January 1980 to March 2023. The search terms included combinations of ‘local’, ‘regional’, ‘locoregional’, ‘loco-regional’, ‘nerve’ with ‘anesthesia’, ‘anaesthesia’, ‘analgesia’, ‘block’ and ‘PCNL’, ‘percutaneous nephrolithotomy’, ‘percutaneous nephrolithotomy’, ‘percutaneous nephrolithotripsy’, ‘percutaneous stone lithotripsy’, ‘ECIRS’, ‘endoscopic combined intrarenal surgery’, ‘miniPCNL’, ‘mini-PCNL’, ‘microPCNL’ and ‘micro-PCNL’. Boolean operators (AND, OR) were used to refine the search. Additionally, we performed a manual search of references from articles included in Scopus, PubMed and Web of Science to avoid missing any relevant publications, and from reference lists of included articles [5].

Selection criteria and abstract screening

Inclusion criteria

  1. Original articles reporting on the peri and postoperative outcomes of PCNL under anaesthesia.

  2. Studies in the English language with a minimum of 20 patients.

Exclusion criteria

  1. Not relevant to the study topic, in vitro or animal study

  2. Review articles, book chapters, thesis

  3. Conference papers, editorials, letters, oral presentations, correspondences, communications, and posters

  4. Studies were done under regional anaesthesia where data on regional anaesthesia could not be separated from those who underwent general anaesthesia

  5. Studies examining PCNL for non-urolithiasis conditions or ureteral stones

  6. Studies that explicitly did not report SFR.

Two independent groups of reviewers (MS, TTN) performed title and abstract screening to select relevant papers. Eligible publications were further screened for inclusion in the systematic review and meta-analysis. Any disagreement was resolved by discussion and consensus (MS, TTN, BKS) if necessary.

Full-text screening and data extraction

Regarding data extraction, two authors (MS and TTN) developed the extraction form using Excel (Microsoft Corp., Redmond, WA, USA). All disagreements and discrepancies were resolved by discussion and consensus. Papers published by the same research group were checked for potential overlapping data based on the period of case recruitment, the center where the cases were recruited, and confirmation from the study authors when necessary. For those studies that selected patients from the same institutions or databases, we chose the studies with the highest number of patients or the most recent data for the primary analyses.

Quality assessment

The Newcastle–Ottawa Scale (NOS) was used to evaluate the quality of studies included in our meta-analyses, in which stars were awarded for cohort or case-control studies (maximum nine stars) based on a developed checklist [6]. Studies that were awarded at least six stars were considered moderate- to high-quality studies, while those with a NOS value of less than six were regarded as low-quality studies [6].

Statistical analysis

A comprehensive Meta-analysis (Englewood, NJ, USA) was used for statistical analyses. Among-study heterogeneity was assessed by the I2 statistic, which shows the total variation across studies that is not a result of chance [7]. An I2 statistic ranging from 25–49%, 50–74%, and ≥75% indicates a low, moderate, and high heterogeneity, respectively [8]. Sensitivity or subgroup analyses were performed to handle heterogeneity. We used risk ratios (RR) with 95% confidential intervals (CI) for categorical variables. The pooled results are presented as a forest plot using random-effects models. Egger's regression test and funnel plot were calculated to assess the presence of publication bias. A p-value of less than 0.05 was considered statistically significant.

RESULTS

Search results and study characteristics

A total of 301 articles were identified from three electronic databases, including Scopus, PubMed, and Web of Science. After screening those articles by title and abstract, 42 articles were selected for full-text assessment. Upon full-text review, 28 articles were excluded due to lack of proper information, study design, and duplication. In total, 14 articles that met the inclusion criteria were included in the final cohort analysis, comprising 3871 cases of PCNL, including 2,154 regional anaesthesia cases and 1717 general anaesthesia cases [922]. The evidence acquisition flow chart is shown in Figure 1. The individual characteristics of all included studies are described in Table 1.

Figure 1.

Figure 1

Evidence acquisition flow chart.

*Records excluded due to single-arm study design or lack of information related with perioperative outcomes

**Includes no reliable or overlapped data.

Table 1.

Characteristics of included studies

Study ID (Author/Year/Country) Study design No. of patients Regional anesthesia No. of cases Percentages of males Sedation Position Type of puncture Type of lithotriptor Sheath size (Fr) Age (years) BMI ASA Stone diameter (mm) Stone burden (mm2)
Regional General Regional General Regional General Regional General Regional General Regional General Regional General Regional General
Singh/India/2011 [9] Randomized 64 L1–L2 32 32 NA NA no no Prone Fluroscopy guidance pneumatic 30 40 39.6 NA NA NA NA 21.9 22.7 NA NA
Kuzgunbay/Turkey/2009 [10] Randomized 82 L3–L4 37 45 64.9 57.8 no no Prone Fluroscopy guidance pneumatic 30 44 45 NA NA NA NA NA NA 731 734
Moslemi/Iran/2012 [11] Retrospective 123 L–2L3 54 69 NA NA NA NA Prone Fluroscopy guidance pneumatic 30–32 39 41 25 26 NA NA NA NA NA NA
Oner/Turkey/2018 [12] Retrospective 138 catheter at t12–L1, sensory level T6–S4 69 69 60.9 53.6 yes no Prone Fluroscopy guidance pneumatic 30 46.4 44.3 28.6 28.3 1.3 1.2 NA NA 867.0 744.2
Tangpaitoon/Turkey/2012 [13] Randomized 50 L1–L2 24 26 70.8 61.5 NA NA Prone Fluroscopy guidance pneumatic 30 53.0 56.6 21.2 21.6 23 (ASA 1–2), 1 (ASA 3) 25 (ASA 1–2), 1 (ASA 3) 40.8 35.4 NA NA
Dar/India/2021 [14] Prospective randomized 230 T9–T10or T10–T11 120 110 55.0 56.4 no no Prone Fluroscopy guidance laser/ Pneumatic 24–28 39.9 38.5 NA NA ASA 1–2 ASA 1–2 61.9 54.6 NA NA
Buldu/Turkey/2016 [15] Retrospective 100 L3–L4 (T4 dermatome) 47 53 70.2 79.2 NA NA Prone Fluroscopy guidance pneumatic 30 48.5 46.1 28.7 27.1 1.4 1.2 52.9 50.6 NA NA
Solakhan/Turkey/2019 [16] Retrospective 1657 l2–l3 1085 572 66.6 59.6 no no Prone Fluroscopy guidance NA 30 34.3 32.7 25.1 24.2 128 (ASA 3) 106 (ASA 3) NA NA 635.2 644.5
Nouralizadeh/Iran/2013 [17] Randomized 100 L3–L4, T6 dermatome 50 50 58.0 54.0 no no Prone Fluroscopy guidance pneumatic+laser 28–30 41.1 42.6 NA NA ASA 1–2 ASA 1–2 55.1 55.6 NA NA
Gonen/Turkey/2013 [18] Retrospective 46 L2–L3 26 20 69.2 65.0 no no Prone Fluroscopy guidance pneumatic 30 45.5 40.8 NA NA NA NA NA NA 558.6 630.4
Shah/Nepal/2016 [19] Randomized 60 l3–l4 (T6 dermatome) 30 30 43.3 63.3 yes no Prone Fluroscopy guidance pneumatic 26–30 36.1 39.1 NA NA ASA 1–2 ASA 1–2 32.3 37.5 NA NA
Kim/Korea/2013 [20] Retrospective 101 L3–4 or L4–5 77 24 61.0 58.3 yes no Prone Ultrasound ltrasonicand pneumatic lithotripsy 28–30 54.8 50.8 25.1 23.3 NA NA 34.5 42.1 NA NA
Cicek/Turkey/2014 [21] Retrospective 1004 L2–L3 440 564 64.3 60.1 yes no Prone Fluroscopy guidance pneumatic 30 48.8 47.2 NA NA 33 (ASA 3) 39 (ASA 3) NA NA 533 529
Karatag/Turkey/2015 [22] Retrospective 116 L3–L4 or L4–L5; T4 dermatome 63 53 NA NA no no Prone Fluroscopy guidance laser 4.8 45.8 30.3 27 25.8 NA NA NA NA 155.0 151

ASA – American Society of Anesthesiologists score; BMI – Body mass index; NA – Not available

Perioperative and postoperative outcomes after percutaneous nephrolithotomy

A summary of this meta-analysis of the characteristics and outcomes of two groups (regional anaesthesia and general anaesthesia) is demonstrated in Table 2. Compared to general anaesthesia, the regional anaesthesia group had a significantly higher age (MD = 1.68 years, 95% CI 0.07 to 3.30, p = 0.041), a higher BMI (MD = 0.9, 95% CI 0.51 to 1.29, p <0.001), a shorter length of stay (MD = -0.34 days, 95% CI -0.56 to -0.12, p = 0.002), lower nephrostomy rates (RR = 0.61, 95% CI 0.5 to 0.7, p <0.001), lower postoperative nausea and vomiting rates (RR = 0.16, 95% CI 0.03 to 0.80, p = 0.026), lower complications grade III–V rates (RR = 0.68, 95% CI 0.52 to 0.89, p = 0.006), and lower postoperative visual analogue pain score (VAS) at 1 hour (MD = -3.5, 95% CI -4.1 to -2.9, p <0.001) [922]. There were no significant differences in other outcomes between the two groups, including the size of the stone, stone burden, operative time, need for auxiliary procedures, stone-free rates (SFR) at 1 month, blood transfusion, complications grade I–II, postoperative visual analogue pain score at 12 hours, postoperative VAS at 24 hours and opioid use (Table 2, Figures 15) [23].

Table 2.

Meta-analysis of the characteristics and perioperative outcomes of percutaneous nephrolithotomy patients between regional and general anesthesia groups

Variables No. of Studies No. of patients Heterogeneity Overall effect
Regional General I2 (%) p-value MD/RR (95% Cl) p-value
Age (year) 13 2100 1648 50 0.019 1.68 (0.07, 3.3) 0.041
BMI 6 1365 797 0 0.642 0.9 (0.51, 1.29) <0.001
Size of stone (mm) 6 348 293 43 0.114 0.7 (-4.0, 5.5) 0.761
Stone burden (mm2) 7 1752 1355 0 0.846 -1.03 (-4.09, 2.02) 0.507
Operative time (minute) 14 2154 1717 94 <0.001 -8.2 (-17.3, 0.8) 0.076
Length of stay (day) 12 2031 1579 89 <0.001 -0.34 (-0.56, -0.12) 0.002
Nephrostomy 2 470 594 0 0.863 0.61 (0.5, 0.7) <0.001
Tubeless PCNL 3 494 620 86 0.001 0.83 (0.32, 2.13) 0.698
Need for auxiliary procedures 6 372 299 0 0.84 1.07 (0.7, 1.4) 0.678
Stone-free rates (SFR) at 1 month 14 2154 1717 0 0.923 1.01 (0.98, 1.03) 0.4
Blood transfusion 9 1827 1455 39 0.102 0.77 (0.5, 1.18) 0.231
Postoperative nausea and vomiting (PONV) 3 104 106 60 0.081 0.16 (0.03, 0.80) 0.026
Complications Grade I–II 14 2154 1717 38 0.07 0.98 (0.79, 1.21) 0.883
Complications Grade III–V 8 1883 1476 0 0.837 0.68 (0.53, 0.88) 0.004
Postoperative visual analog pain score at 1 hour 2 144 136 0 0.59 -3.5 (-4.1, -2.9) <0.001
Postoperative visual analog pain score at 12 hours 2 144 136 0 0.708 -0.4 (-0.88, 0.03) 0.07
Postoperative visual analog pain score at 24 hours 2 144 136 0 0.885 -0.15 (-0.60, 0.30) 0.512
Opioid use 2 76 70 97 <0.001 -3.1 (-6.6, 0.3) 0.077

PCNL – percutaneous nephrolithotomy; CI – confidence interval; MD – mean difference; RR – risk ratio

Figure 5.

Figure 5

Forest plots for the meta-analysis comparing the outcomes of percutaneous nephrolithotomy patients between regional anesthesia and general anesthesia groups: (a) Blood transfusion; (b) Postoperative nausea and vomiting (PONV); (c) Complications Grade I–II; (d) Complications Grade III–V.

Figure 2.

Figure 2

Forest plots for the meta-analysis comparing the characteristics of percutaneous nephrolithotomy patients between regional anesthesia and general anesthesia groups: (a) Age; (b) BMI; (c) Size of stone; (d) Stone burden, (e) Tubeless percutaneous nephrolithotomy.

PCNL – percutaneous nephrolithotomy

Figure 3.

Figure 3

Forest plots for the meta-analysis comparing the outcomes of percutaneous nephrolithotomy patients between regional anaesthesia and general anaesthesia groups: (a) Postoperative visual analog pain score at 1 hour; (b) Postoperative visual analog pain score at 12 hours; (c) Postoperative visual analog pain score at 24 hours; (d) Opioid use.

Figure 4.

Figure 4

Forest plots for the meta-analysis comparing the outcomes of percutaneous nephrolithotomy patients between local anesthesia and general anaesthesia groups: (a) Operative time; (b) Length of stay; (c) Nephrostomy; (d) Need for auxiliary procedures; (e) Stone-free rates (SFR) at 1 month.

The heterogeneity of the operative time, length of stay, and opioid use was high (I2 = 94%, 89%, and 94%, respectively). We used sensitivity analysis to assess the heterogeneity (Figure 6).

Figure 6.

Figure 6

Forest plots for the sensitivity analysis by the “one-study-removed” procedure comparing the outcomes of percutaneous nephrolithotomy patients between regional anesthesia and general anesthesia groups: (a) Operative time, (b) Length of stay, (c) Opioid use, (d) Tubeless percutaneous nephrolithotomy.

PCNL – percutaneous nephrolithotomy

Risk of bias assessment

The NOS tool was used to evaluate the study’s quality. Most of the included studies were retrospective (n = 8), with five randomised studies [9, 10, 13, 17, 19]. The number of stars awarded to each included study ranged from six to nine. Details of the given stars within each NOS domain are shown in Table 3.

Table 3.

Quality assessment for the included studies

Author/country/year Selection Comparability of cohorts Outcome Total
Representative of the exposed cohort Selection of external control Ascertainment of exposure Outcome of interest not present at the start of the study Main factor Additional factor Assessement of outcomes Sufficient follow-up time Adequecy of follow-up
Singh/India/2011 [9] * * * * * * * * 0 8
Kuzgunbay/Turkey/2009 [10] * * * * * * * * 0 8
Moslemi/Iran/2012 [11] * 0 * * * 0 * * 0 6
Oner/Turkey/2018 [12] * 0 * * * 0 * * 0 6
Tangpaitoon/Turkey/2012 [13] * * * * * * * * 0 8
Dar/India/2021 [14] * * * * * * * * * 9
Buldu/Turkey/2016 [15] 0 * * * * * * * 0 7
Solakhan/Turkey/2019 [16] * * * * * * * * 0 8
Nouralizadeh/Iran/2013 [17] * * * * * * * * 0 8
Gonen/Turkey/2013 [18] * 0 * * * * * * * 8
Shah/Nepal/2016 [19] * * * * * * * * 0 8
Kim/Korea/2013 [20] * 0 * * * 0 * * 0 6
Cicek/Turkey/2014 [21] * * * * * 0 * * 0 7
Karatag/Turkey/2015 [22] 0 * * * * * * * 0 7

Publication bias

We used Egger's regression test to assess the publication bias, and it did not suggest any evidence of bias, as confirmed by Egger's regression test (p = 0.896). Moreover, the funnel plot showed no evidence of asymmetry (Figure 7).

Figure 7.

Figure 7

Funnel plot shows no evidence of asymmetry which was further confirmed by the Egger's regression test (p = 0.896).

DISCUSSION

In the minimally invasive therapy era, urologists have made great efforts in modifying the technique to increase the safety, efficacy, and outcomes of PCNL. Previous meta-analyses have been performed to evaluate the impact of different anaesthesia modalities on PCNL outcomes [2426]. However, in the last four years, there have been some new studies with larger data published as well as changes in clinical practice, our recent meta-analysis could provide updated evidence and evaluate the current outcomes.

Firstly, our recent study found that the patients undergoing regional anaesthesia had a significantly higher age and BMI compared to those under general anaesthesia [16, 20, 22]. This finding indicated a difference between these two approaches in patient selection, which is an important factor to consider. Regional anaesthesia is an optimal option in patients with higher age and BMI, who have a higher risk of respiratory and cardiovascular events, and anaesthesia-related complications.

Secondly, our results found that regional anaesthesia had a lower postoperative nausea and vomiting rate and a lower immediate postoperative visual analog pain score [13, 14, 19]. Although these two approaches had no significant difference in postoperative visual analog pain score at 12 hours and 24 hours, these findings indicate the advantages of regional anaesthesia compared to general anaesthesia in PCNL. These results are consistent with a previous meta-analysis [25]. In our study, we also found that the regional anaesthesia group had a shorter stay length than the general anaesthesia group [27]. In addition, regional anaesthesia patients also offer a lower cost of anaesthesia and better health-economic benefits [28].

Thirdly, regarding surgical outcomes, the regional anaesthesia group had a lower nephrostomy rate and lower complications grade III–IV rates with the same size of stone and stone burden, and the similar efficacy in operative time, blood transfusion, complication grade I–II, need for the auxiliary procedure, and SFR at 1 month [13, 21].

Overall, our study highlights some advantages of regional anaesthesia compared to general anaesthesia, such as lower postoperative nausea and vomiting rates, lower complication grade III–IV rates, and a shorter length of stay. Furthermore, patient selection plays an important role when choosing anaesthesia techniques, which depends on individual patient characteristics and possibly patient counselling.

The meta-analysis study design of this study has some inherent limitations. The included studies used various regional anaesthesia approaches, puncture types, sheath sizes, and lithotriptor types, resulting in heterogeneity. Furthermore, the short-term follow-up of the published studies limits the comparison of long-term outcomes, although this may be a minor concern as early outcomes should be validated before comparing longer-term results with new approaches. Finally, the regional anaesthesia group used different anaesthesia levels in the included studies. Despite these limitations, this study is the most comprehensive meta-analysis of the subject; It provides health systems and surgeons with insights into the potential benefits of regional anaesthesia in PCNL.

CONCLUSIONS

Our results show that PCNL under regional anaesthesia is safe and feasible, with comparable results to those under general anaesthesia. While the results are similar, PCNL under regional anaesthesia had a reduced rate of postoperative nausea and vomiting, immediate post-operative pain, major complications, and length of hospital stay. While patient selection is important, counselling and decision-making for these procedures must go hand in hand to achieve the best clinical outcomes.

CONFLICTS OF INTEREST

The authors declare no conflicts of interest.

References

  • 1.Skolarikos A, Jung H, Neisius A, et al. EAU Guidelines on Urolithiasis: European Association of Urology. 2023. Available at: http://uroweb.org/guideline/urolithiasis/ [Google Scholar]
  • 2.Fernström I, Johansson B. Percutaneous pyelolithotomy. A new extraction technique. Scand J Urol Nephrol. 1976; 10: 257-259. [DOI] [PubMed] [Google Scholar]
  • 3.Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev. 2021; 10: 89. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Shea BJ, Reeves BC, Wells G, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017; 358: j4008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Vassar M, Atakpo P, Kash MJ. Manual search approaches used by systematic reviewers in dermatology. J Med Libr Assoc. 2016; 104: 302-304. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Wells G, Shea B, O'Connell D, et al. The Newcastle–Ottawa Scale (NOS) for Assessing the Quality of Non-Randomized Studies in Meta-Analysis. 2000; Avaiable at: https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
  • 7.Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002; 21: 1539-1558. [DOI] [PubMed] [Google Scholar]
  • 8.Ioannidis JP, Patsopoulos NA, Evangelou E. Uncertainty in heterogeneity estimates in meta-analyses. BMJ. 2007; 335: 914-916. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Singh V, Sinha RJ, Sankhwar SN, Malik A. A prospective randomized study comparing percutaneous nephrolithotomy under combined spinal-epidural anesthesia with percutaneous nephrolithotomy under general anesthesia. Urol Int. 2011; 87: 293-298. [DOI] [PubMed] [Google Scholar]
  • 10.Kuzgunbay B, Turunc T, Akin S, Ergenoglu P, Aribogan A, Ozkardes H. Percutaneous nephrolithotomy under general versus combined spinal-epidural anesthesia. J Endourol. 2009; 23: 1835-1838. [DOI] [PubMed] [Google Scholar]
  • 11.Moslemi MK, Mousavi-Bahar SH, Abedinzadeh M. The feasibility of regional anesthesia in the percutaneous nephrolithotomy with supracostal approach and its comparison with general anesthesia. Urolithiasis. 2013; 41: 53-57. [DOI] [PubMed] [Google Scholar]
  • 12.Öner S AB, Önen E, Kılıç M, Aydos MM, Demirbaş M, Yürekli AE. A Comparison of Epidural Anesthesia without Motor Block Versus General Anesthesia for Percutaneous Nephrolithotomy. J Urol Surg. 2018; 5: 143-148. [Google Scholar]
  • 13.Tangpaitoon T, Nisoog C, Lojanapiwat B. Efficacy and safety of percutaneous nephrolithotomy (PCNL): a prospective and randomized study comparing regional epidural anesthesia with general anesthesia. Int Braz J Urol. 2012; 38: 504-511. [DOI] [PubMed] [Google Scholar]
  • 14.Dar MA, Malik SA, Dar YA, et al. Comparison of percutaneous nephrolithotomy under epidural anesthesia versus general anesthesia: A randomized prospective study. Urol Ann. 2021; 13: 210-214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Buldu I, Tepeler A, Kaynar M, et al. Comparison of Anesthesia Methods in Treatment of Staghorn Kidney Stones with Percutaneous Nephrolithotomy. Urol J. 2016; 13: 2479-2483. [PubMed] [Google Scholar]
  • 16.Solakhan M, Bulut E, Erturhan MS. Comparison of Two Different Anesthesia Methods in Patients Undergoing Percutaneous Nephrolithotomy. Urol J. 2019; 16: 246-250. [DOI] [PubMed] [Google Scholar]
  • 17.Nouralizadeh A, Ziaee SA, Hosseini Sharifi SH, et al. Comparison of percutaneous nephrolithotomy under spinal versus general anesthesia: a randomized clinical trial. J Endourol. 2013; 27: 974-978. [DOI] [PubMed] [Google Scholar]
  • 18.Gonen M, Basaran B. Tubeless percutaneous nephrolithotomy: spinal versus general anesthesia. Urol J. 2014; 11: 1211-1215. [PubMed] [Google Scholar]
  • 19.Shah R, Thapa AS, Lamichhane N, Kc SR. Safety and Efficacy of Spinal Anaesthesia in Percutaneous Nephrolithotomy. JNMA J Nepal Med Assoc. 2016; 55: 61-66. [PubMed] [Google Scholar]
  • 20.Kim SS, Lee JW, Yu JH, Sung LH, Chung JY, Noh CH. Percutaneous nephrolithotomy: comparison of the efficacies and feasibilities of regional and general anesthesia. Korean J Urol. 2013; 54: 846-850. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Cicek T, Gonulalan U, Dogan R, et al. Spinal anesthesia is an efficient and safe anesthetic method for percutaneous nephrolithotomy. Urology. 2014; 83: 50-55. [DOI] [PubMed] [Google Scholar]
  • 22.Karatag T, Tepeler A, Buldu I, et al. Is micro-percutaneous nephrolithotomy surgery technically feasible and efficient under spinal anesthesia? Urolithiasis. 2015; 43: 249-254. [DOI] [PubMed] [Google Scholar]
  • 23.Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009; 250: 187-196. [DOI] [PubMed] [Google Scholar]
  • 24.Hu H, Qin B, He D, et al. Regional versus General Anesthesia for Percutaneous Nephrolithotomy: A Meta-Analysis. PLoS One. 2015; 10: e0126587. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Liu X, Huang G, Zhong R, Hu S, Deng R. Comparison of Percutaneous Nephrolithotomy Under Regional versus General Anesthesia: A Meta-Analysis of Randomized Controlled Trials. Urol Int. 2018; 101: 132-142. [DOI] [PubMed] [Google Scholar]
  • 26.Pu C, Wang J, Tang Y, et al. The efficacy and safety of percutaneous nephrolithotomy under general versus regional anesthesia: a systematic review and meta-analysis. Urolithiasis. 2015; 43: 455-466. [DOI] [PubMed] [Google Scholar]
  • 27.Carli F, Mayo N, Klubien K, Schricker T, Trudel J, Belliveau P. Epidural analgesia enhances functional exercise capacity and health-related quality of life after colonic surgery: results of a randomized trial. Anesthesiology. 2002; 97: 540-549. [DOI] [PubMed] [Google Scholar]
  • 28.Lewis SC, Warlow CP, Bodenham AR, et al. General anaesthesia versus local anaesthesia for carotid surgery (GALA): a multicentre, randomised controlled trial. Lancet. 2008; 372: 2132-2142. [DOI] [PubMed] [Google Scholar]

Articles from Central European Journal of Urology are provided here courtesy of Polish Urological Association

RESOURCES